MENU
KYTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Kyverna Therapeutics (KYTX) Earnings Date & Reports

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

A.I. Advisor
published Earnings

KYTX is expected to report earnings to rise 63.64% to -108 cents per share on August 18

Kyverna Therapeutics KYTX Stock Earnings Reports
Q2'26
Est.
$-1.08
Q1'26
Beat
by $0.38
Q4'25
Beat
by $0.21
Q3'25
Beat
by $0.17
Q2'25
Beat
by $0.05
The last earnings report on May 12 showed earnings per share of -66 cents, beating the estimate of -103 cents. With 98.49K shares outstanding, the current market capitalization sits at 504.90M.
View a ticker or compare two or three
KYTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
5980 Horton Street
Phone
+1 510 925-2492
Employees
130
Web
https://www.kyvernatx.com